Abstract |
Central nervous system (CNS) injuries, such as stroke, traumatic brain injury (TBI) and spinal cord injury (SCI), are important causes of death and long-term disability worldwide. MicroRNA ( miRNA), small non-coding RNA molecules that negatively regulate gene expression, can serve as diagnostic biomarkers and are emerging as novel therapeutic targets for CNS injuries. MiRNA-based therapeutics include miRNA mimics and inhibitors ( antagomiRs) to respectively decrease and increase the expression of target genes. In this review, we summarize current miRNA-based therapeutic applications in stroke, TBI and SCI. Administration methods, time windows and dosage for effective delivery of miRNA-based drugs into CNS are discussed. The underlying mechanisms of miRNA-based therapeutics are reviewed including oxidative stress, inflammation, apoptosis, blood-brain barrier protection, angiogenesis and neurogenesis. Pharmacological agents that protect against CNS injuries by targeting specific miRNAs are presented along with the challenges and therapeutic potential of miRNA-based therapies.
|
Authors | Ping Sun, Da Zhi Liu, Glen C Jickling, Frank R Sharp, Ke-Jie Yin |
Journal | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
(J Cereb Blood Flow Metab)
Vol. 38
Issue 7
Pg. 1125-1148
(07 2018)
ISSN: 1559-7016 [Electronic] United States |
PMID | 29708005
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
|
Chemical References |
|
Topics |
- Animals
- Apoptosis
(drug effects)
- Blood-Brain Barrier
(metabolism, pathology)
- Brain Injuries, Traumatic
(metabolism, pathology, therapy)
- Drug Delivery Systems
(methods)
- Humans
- Inflammation
(metabolism, pathology, therapy)
- MicroRNAs
(therapeutic use)
- Oxidative Stress
(drug effects)
- Spinal Cord Injuries
(metabolism, therapy)
- Stroke
(metabolism, pathology, therapy)
|